Reportlinker Adds The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

NEW YORK, March 30 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

http://www.reportlinker.com/p0184374/The-Future-of-Pain-Management-Therapeutics-Analysis-and-Market-Forecasts-to-2016---Increasing-Generic-Competition-Creates-Challenges.html

The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

Summary

GBI Research has released its research - "The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges". The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.

- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.

- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.

- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns.

- Key drivers and barriers that have a significant impact on the market.

- Coverage of pipeline molecules in the various phases of drug development.

- Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.

- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to

- Align product portfolio to the markets with high growth potential

- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth

- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety

- Develop key strategic initiatives by understanding key focus areas of leading companies

- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 10

2 Global Pain Management Therapeutics Market: Introduction 13

2.1 GBI Research Report Guidance 13

3 Global Pain Management Therapeutics Market: Market Overview 14

3.1 Introduction 14

3.2 Revenue Forecast for the Global Pain Management Therapeutics Market 15

3.2.1 Sales Value 15

3.2.2 Patient Volume 16

3.2.3 Annual Cost of Therapy 17

3.2.4 Treatment Usage Patterns 18

3.2.5 Generics' Share in the Global Pain Management Therapeutics Market 23

3.2.6 Sales of Leading Drugs 24

3.3 Pain Management Therapeutics Market Drivers 25

3.3.1 Increase in Diagnosed and Prescription Population 25

4 Global Pain Management Therapeutics Market: Therapeutic Landscape 26

4.1 Fibromyalgia Market 26

4.1.1 Introduction 26

4.1.2 Sales Value 26

4.1.3 Patient Volume 28

4.1.4 Annual Cost of Therapy 29

4.1.5 Treatment Usage Patterns 30

4.1.6 Drivers for Fibromyalgia Pain Market 35

4.1.7 Restraints for Fibromyalgia Pain Market 36

4.1.8 Unmet Needs 36

4.2 Neuropathic Pain Market 36

4.2.1 Introduction 36

4.2.2 Sales Value 37

4.2.3 Patient Volume 38

4.2.4 Annual Cost of Therapy 39

4.2.5 Treatment Usage Patterns 40

4.2.6 Drivers for Neuropathic Pain Market 45

4.2.7 Restraints for Neuropathic Pain Market 46

4.2.8 Unmet Need 46

4.3 Migraine Market 46

4.3.1 Introduction 46

4.3.2 Sales Value 47

4.3.3 Patient Volume 48

4.3.4 Annual Cost of Therapy 49

4.3.5 Treatment Usage Patterns 50

4.3.6 Drivers for Migraine Market 55

4.3.7 Restraints for Migraine Market 55

4.3.8 Unmet Need 56

4.4 Cancer Pain Market 56

4.4.1 Introduction 56

4.4.2 Sales Value 56

4.4.3 Patient Volume 58

4.4.4 Annual Cost of Therapy 59

4.4.5 Treatment Usage Patterns 60

4.4.6 Drivers for Cancer Pain Market 64

4.4.7 Restraints for Cancer Pain Market 65

4.4.8 Unmet Need 65

4.5 Osteoarthritis Pain Market 65

4.5.1 Introduction 65

4.5.2 Sales Value 66

4.5.3 Patient Volume 67

4.5.4 Annual Cost of Therapy 68

4.5.5 Treatment Usage Patterns 69

4.5.6 Drivers for Osteoarthritis Pain Market 73

4.5.7 Restraints for Osteoarthritis Pain Market 74

4.5.8 Unmet Need 74

5 Global Pain Management Therapeutics Market: Geographical Landscape 75

5.1 Geographical Break-up 75

5.2 The US 77

5.2.1 Sales Value 77

5.2.2 Patient Volume 78

5.2.3 Annual Cost of Therapy 79

5.2.4 Treatment Usage Patterns 80

5.3 Top Five Countries in Europe 85

5.3.1 Sales Value 85

5.3.2 Patient Volume 86

5.3.3 Annual Cost of Therapy 87

5.3.4 Treatment Usage Patterns 88

5.4 Japan 93

5.4.1 Sales Value 93

5.4.2 Patient Volume 94

5.4.3 Annual Cost of Therapy 95

5.4.4 Treatment Usage Patterns 96

6 Global Pain Management Therapeutics Market: Pipeline Analysis 102

6.1 Introduction 102

6.1.1 Research and Development Pipeline – Fibromyalgia 103

6.1.2 Research and Development Pipeline – Neuropathic Pain 104

6.1.3 Research and Development Pipeline – Migraine 105

6.1.4 Research and Development Pipeline – Cancer Pain 106

6.1.5 Research and Development Pipeline – Osteoarthritis Pain 106

6.2 Profiles of Key Late-Stage Drugs in the Pain Management Market 107

6.2.1 Droxopida 107

6.2.2 Xyrem 107

6.2.3 Vimpat (lacosamide) 107

6.2.4 Qutenza (capsaicin 8%) 108

6.2.5 Botox 109

6.2.6 Tezampanel 110

6.2.7 Nasalfent 110

6.2.8 PF-4383119 (Tanezumab) 111

7 Global Pain Management Therapeutics Market: Competitive Landscape 112

7.1 Market Share Analysis 112

7.2 Competitive Profiling 112

7.2.1 Pfizer, Inc. 114

7.2.2 Eli Lilly and Company 115

7.2.3 Johnson & Johnson 117

7.2.4 Endo Pharmaceuticals 119

7.2.5 Novartis AG 120

7.2.6 Merck & Co Inc 122

7.2.7 Cephalon, Inc. 123

8 Global Pain Management Therapeutics Market: Strategic Consolidations 125

8.1 Overview 125

8.1.1 Sanofi-Aventis Acquired 100% outstanding shares of Chattem, Inc in December 2009 127

8.1.2 Dainippon Sumitomo Pharma Acquired Sepracor, Inc. in October 2009 127

8.1.3 Raptor Pharmaceuticals and TorreyPines Therapeutics Merged in August 2009 127

8.1.4 Alexza Pharmaceuticals Acquired Symphony Allegro in June 2009 127

8.1.5 Anesiva and Arcion Therapeutics Merge in May 2009 127

8.1.6 Mylan Laboratories Acquired Matrix Laboratories Limited in March 2009 128

8.2 R&D Licensing Agreements 128

8.2.1 Deals by Indication 128

8.2.2 Deals by Phase 129

8.2.3 Deals by Geography 130

8.2.4 Deals by Value ($) 131

8.2.5 Preclinical and Discovery 131

8.2.6 Phase I 132

8.2.7 Phase II 132

8.2.8 Phase III 133

8.2.9 Approved and Regulatory Filing 134

9 Global Pain Management Therapeutics Market: Appendix 136

9.1 Market Definitions 136

9.2 Abbreviations 136

9.3 Research Methodology 137

9.3.1 Coverage 137

9.3.2 Secondary Research 138

9.3.3 Primary Research 138

9.3.4 Forecasts 138

9.3.5 Expert Panel Validation 140

9.4 Contact Us 141

9.5 Disclaimer 141

9.6 Sources 141

1.1 List of Tables

Table 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2009 16

Table 2: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2009-2016 16

Table 3: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2001-2009 17

Table 4: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2009-2016 17

Table 5: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2001-2009 18

Table 6: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2009-2016 18

Table 7: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009 19

Table 8: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016 20

Table 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 24

Table 10: Pain Management Therapeutics Market, Global, Sales of Leading Drugs, 2009 25

Table 11: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2001-2009 28

Table 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2009-2016 28

Table 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2009 29

Table 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2009-2016 29

Table 15: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2009 30

Table 16: T Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2009-2016 30

Table 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 32

Table 18: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2009-2016 32

Table 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2001-2009 38

Table 20: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2009-2016 38

Table 21: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2001-2009 39

Table 22: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2009-2016 39

Table 23: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2001-2009 40

Table 24: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2009-2016 40

Table 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2001-2009 41

Table 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2009-2016 42

Table 27: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2009 48

Table 28: Pain Management Therapeutics Market, Global, Migraine Diseases Population ($ bn), 2009-2016 48

Table 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2009 49

Table 30: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2009-2016 49

Table 31: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2009 50

Table 32: Pain Management Therapeutics Market, Global, Annual Cost of Migraine Treatment ($), 2001-2009 50

Table 33: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2001-2009 52

Table 34: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2009-2016 52

Table 35: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2001-2009 58

Table 36: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2009-2016 58

Table 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2009 59

Table 38: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2009-2016 59

Table 39: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2009 60

Table 40: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2009-2016 60

Table 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2001-2009 61

Table 42: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2009-2016 62

Table 43: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2001-2009 67

Table 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2009-2016 67

Table 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2001-2009 68

Table 46: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2009-2016 68

Table 47: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2009 69

Table 48: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2009-2016 69

Table 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2001-2009 70

Table 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2009-2016 71

Table 51: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009 77

Table 52: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016 77

Table 53: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2009 78

Table 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2009-2016 78

Table 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2009 79

Table 56: Pain Management Therapeutics Market, US, Patient Volume (million), 2009-2016 79

Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009 80

Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016 80

Table 59: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2001-2009 81

Table 60: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2009-2016 82

Table 61: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009 86

Table 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016 86

Table 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2009 87

Table 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2009-2016 87

Table 65: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009 88

Table 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016 88

Table 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2009 89

Table 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2009-2016 90

Table 69: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009 94

Table 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016 94

Table 71: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2001-2009 95

Table 72: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2009-2016 95

Table 73: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009 96

Table 74: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016 96

Table 75: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2009 98

Table 76: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions) , 2009-2016 98

Table 77: Pain Management Therapeutics Market, Global, Competitive Landscape, 2009 114

Table 78: Pain Management Therapeutics Market, Merck, Pipeline Products, December 2009 116

Table 79: Pain Management Therapeutics Market, Eli Lilly, Pipeline Products, 2010 117

Table 80: Pain Management Therapeutics Market, J&J, Pipeline Products, 2010 120

Table 81: Pain Management Therapeutics Market, Endo Pharmaceuticals, Pipeline Products, 2010 121

Table 82: Pain Management Therapeutics Market, Novartis, Pipeline Products, 2010 123

Table 83: Pain Management Therapeutics Market, Merck & Co, Inc., Pipeline Products, 2010 124

Table 84: Cephalon Inc. – Pain Pipeline Products, 2009 125

Table 85: Pain Management Therapeutics Market, Global, Major M&A Deals, 2009-2010 127

Table 86: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-2009 132

Table 87: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2009 133

Table 88: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2009 133

Table 89: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2009 134

Table 90: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs Which are Approved or Awaiting Approval, 2008-2009 135

1.2 List of Figures

Figure 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2000-2016 15

Figure 2: Pain Management Therapeutics Market, Global, Volume (Millions), 2001-2016 16

Figure 3: Pain Management Therapeutics Market, Global, Annual Cost of Therapy ($),

2000-2015 17

Figure 4: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 18

Figure 5: Pain Management Therapeutics Market, Global, Diseased Population (Millions),

2001-2016 19

Figure 6: Pain Management Therapeutics Market, Global, Treatment Seeking Population (Millions), 2001-2016 20

Figure 7: Pain Management Therapeutics Market, Global, Diagnosed Population (Millions), 2001-2016 21

Figure 8: Pain Management Therapeutics Market, Global, Prescription Population (Millions), 2001-2016 22

Figure 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 23

Figure 10: Pain Management Therapeutics Market, Global, Growth Parameters, 2009 25

Figure 11: Pain Management Therapeutics Market, Global, Sales Value by Indication (%) 2009 and 2016 26

Figure 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($ bn), 2001-2016 27

Figure 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2016 28

Figure 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2016 29

Figure 15: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 30

Figure 16: Pain Management Therapeutics Market, Global, Fibromyalgia Diseased Population (Millions), 2001-2016 32

Figure 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Seeking Population (Millions), 2001-2016 33

Figure 18: Pain Management Therapeutics Market, Global, Fibromyalgia Diagnosed Population (Millions), 2001-2016 34

Figure 19: Pain Management Therapeutics Market, Global, Fibromyalgia Prescription Population (Millions), 2001-2016 35

Figure 20: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2016 37

Figure 21: Pain Management Therapeutics Market, Global, Neuropathic Pain, Patient Volume (Millions), 2001-2016 38

Figure 22: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Therapy ($), 2001-2016 39

Figure 23: Pain Management Therapeutics Market, Global, Neuropathic Treatment Usage Patterns, 2001-2016 40

Figure 24: Pain Management Therapeutics Market, Global, Neuropathic Pain Diseased Population (Millions), 2001-2016 42

Figure 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Seeking Population (Millions), 2001-2016 43

Figure 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Diagnosed Population (Millions), 2001-2016 44

Figure 27: Pain Management Therapeutics Market, Global, Neuropathic Pain Prescription Population (Millions), 2001-2016 45

Figure 28: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn),

2001-2016 47

Figure 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2016 48

Figure 30: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2016 49

Figure 31: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions) , 2001-2016 50

Figure 32: Pain Management Therapeutics Market, Global, Migraine Diseased Population (Millions), 2001-2016 52

Figure 33: Pain Management Therapeutics Market, Global, Migraine Treatment Seeking Population (Millions), 2001-2016 53

Figure 34: Pain Management Therapeutics Market, Global, Migraine Diagnosed Population (Millions), 2001-2016 54

Figure 35: Pain Management Therapeutics Market, Global, Migraine Prescription Population (Millions), 2001-2016 55

Figure 36: Pain Management Therapeutics Market, Global, Cancer Pain Sales Value ($ bn),

2001-2016 57

Figure 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2016 58

Figure 38: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2016 59

Figure 39: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns, 2001-2016 60

Figure 40: Pain Management Therapeutics Market, Global, Cancer Pain Diseased Population, 2001-2016 61

Figure 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Seeking Population, 2001-2016 62

Figure 42: Pain Management Therapeutics Market, Global, Cancer Pain Diagnosed Population, 2001-2016 63

Figure 43: Pain Management Therapeutics Market, Global, Cancer Pain Prescription Population, 2001-2016 64

Figure 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($ bn), 2001-2016 66

Figure 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (Millions), 2001-2016 67

Figure 46: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2016 68

Figure 47: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns, 2001-2016 69

Figure 48: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diseased Population, 2001-2016 70

Figure 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Seeking Population, 2001-2016 71

Figure 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diagnosed Population, 2001-2016 72

Figure 51: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Prescription Population, 2001-2016 73

Figure 52: Pain Management Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 75

Figure 53: Pain Management Therapeutics Market, Global, Sales Value by Geography ($bn), 2001-2016 76

Figure 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2016 77

Figure 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2016 78

Figure 56: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 79

Figure 57: Pain Management Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 80

Figure 58: Pain Management Therapeutics Market, US, Diseased Population (Millions),

2001-2016 81

Figure 59: Pain Management Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 82

Figure 60: Pain Management Therapeutics Market, US, Diagnosed Population (Millions),

2001-2016 83

Figure 61: Pain Management Therapeutics Market, US, Prescription Population (Millions),

2001-2016 84

Figure 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value

($ bn), 2001-2016 85

Figure 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2016 86

Figure 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 87

Figure 65,: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2016 88

Figure 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 89

Figure 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016 90

Figure 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 91

Figure 69: Pain Management Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 92

Figure 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 93

Figure 71: Pain Management Therapeutics Market, Japan, Patient Volume (million) , 2001-2016 94

Figure 72: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($),

2001-2016 95

Figure 73: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2016 96

Figure 74: Pain Management Therapeutics Market, Japan, Diseased Population (Millions),

2001-2016 98

Figure 75: Pain Management Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 99

Figure 76: Pain Management Therapeutics Market, Japan, Diagnosed Population (Millions),

2001-2016 100

Figure 77: Pain Management Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 101

Figure 78: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication, December 2009 102

Figure 79: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase, December 2009 102

Figure 80: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Fibromyalgia, March 2010 103

Figure 81: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Neuropathic Pain, March 2010 104

Figure 82: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Migraine, March 2010 105

Figure 83: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Cancer Pain, March 2010 106

Figure 84: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Osteoarthritis, March 2010 106

Figure 85: Pain Management Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 112

Figure 86: Pain Management Therapeutics Market, Global, Pfizer, Share of Key Pain Drugs Revenue, 2009 114

Figure 87: Pain Management Therapeutics Market, Global, Eli Lilly and Company, Share of Key Pain Drugs Revenue, 2009 116

Figure 88: Pain Management Therapeutics Market, Global, Johnson & Johnson, Share of Key Pain Drugs Revenue, 2009 118

Figure 89: Pain Management Therapeutics Market, Global, Endo Pharmaceuticals, Share of Key Pain Drugs Revenue, 2009 119

Figure 90: Pain Management Therapeutics Market, Global, Novartis, Share of Key Pain Drugs Revenue, 2009 121

Figure 91: Pain Management Therapeutics Market, Global, Merck & Co, Inc., Share of Key Pain Drugs Revenue, 2009 123

Figure 92: Pain Management Therapeutics Market, Global, Cephalon, Share of Key Pain Drugs Revenue, 2009 124

Figure 93: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Indication, 2008-2010 128

Figure 94: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Phase, 2008-2010 129

Figure 95: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-2010 130

Figure 96: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-2010, n=8 131

Figure 97: GBI Research Methodology, 2010 137

Figure 98: GBI Research Market Forecasting Model, 2010 140

Companies mentioned

Pfizer, Inc.

Eli Lilly and Company

Johnson & Johnson

Endo Pharmaceuticals

Novartis AG

Merck & Co Inc

Cephalon, Inc.

To order this report:

Healthcare Industry: The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

    
    
    Contact: 
    Nicolas Bombourg
    Reportlinker
    Email: [email protected]
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker